Biohaven Pharmaceutical Holding (BHVN) stock forecast for 2022 – 2027

Are you interested in Biohaven Pharmaceutical Holding Company Ltd. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BHVN stock price in 2022-2027. Is BHVN a good long term stock? When should I take profit in Biohaven Pharmaceutical Holding stock? Buy or sell stock? Will BHVN stock price go up? What are analysts’ forecasts for BHVN stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BHVN stock returns are also predicted based on historical data.

According to our research, BHVN stock is a very good long-term investment. BHVN share price has been in a positive cycle for the past year. Biohaven Pharmaceutical Holding Company Ltd. stock trend is positive.

Biohaven Pharmaceutical Holding company info

Industry Biotechnology
Address 215 Church Street, New Haven, CT, 06510, United States
Website https://www.biohavenpharma.com

Forecasting

52 Week High: 173.666 USD
52 Week Low: 127.151 USD
1 Year Forecast: 175.086 USD
5 Year Forecast: 343.869 USD

Agilent Technologies info

Market Cap: 8.7B
52 Week Change: 47.503%
52 Week High: 151.51 USD
52 Week Low: 62.57 USD
Beta: 1.22882
50 Day Moving Average: 125.2
90 Day Moving Average: 121.292
200 Day Moving Average: 126.63
Resistance Level: 141.811
Pivot Point: 130.017
Support Level: 123.918
Enterprise Value: 8,475,415,040
Forward P/E: -21.70
Forward EPS: -5.88
Profit Margin: -281.24%
Shares Outstanding: 65,501,300
EBITDA: -12.38
Held Percent Institutions: 92.78%
PEG Ratio (5Y): 0
Trailing EPS: -13.7

Biohaven Pharmaceutical Holding stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Biohaven Pharmaceutical Holding Stock Forecast for 2022

March 2022 132.6 125.24 -5.55%
April 2022 121.52 134.64 10.8%
May 2022 134.64 144.54 7.35%
June 2022 143.08 151.5 5.88%
July 2022 153 153.45 0.29%
August 2022 154 159 3.25%
September 2022 157.41 161.37 2.52%
October 2022 164 171.36 4.49%
November 2022 164.64 162.36 -1.38%
December 2022 160.72 169.54 5.49%

Biohaven Pharmaceutical Holding Stock Forecast for 2023

January 2023 173 170.28 -1.57%
February 2023 174.73 177.48 1.57%
March 2023 173.25 169 -2.45%
April 2023 172.38 180 4.42%
May 2023 178.2 188.1 5.56%
June 2023 187.18 195.94 4.68%
July 2023 193.05 197.01 2.05%
August 2023 194.04 200.97 3.57%
September 2023 199.92 212.16 6.12%
October 2023 208 216.24 3.96%
November 2023 209.88 206.91 -1.42%
December 2023 211.09 220.18 4.31%

Biohaven Pharmaceutical Holding Stock Forecast for 2024

January 2024 218 219.17 0.54%
February 2024 221.34 216.81 -2.05%
March 2024 216.81 216.14 -0.31%
April 2024 208.74 229.5 9.95%
May 2024 229.5 237.35 3.42%
June 2024 237 241.39 1.85%
July 2024 234.22 240.57 2.71%
August 2024 243 252.96 4.1%
September 2024 253.98 252 -0.78%
October 2024 246.96 257 4.07%
November 2024 251.86 251.46 -0.16%
December 2024 255.53 264.62 3.56%

Biohaven Pharmaceutical Holding Stock Forecast for 2025

January 2025 264.62 256.76 -2.97%
February 2025 257.74 264 2.43%
March 2025 261.36 252.84 -3.26%
April 2025 258 274.38 6.35%
May 2025 271.69 273.42 0.64%
June 2025 278.19 278.32 0.05%
July 2025 289.68 293.76 1.41%
August 2025 285.12 286.16 0.36%
September 2025 298.86 296 -0.96%
October 2025 299.97 307.02 2.35%
November 2025 305.02 300.98 -1.32%
December 2025 292.04 303.93 4.07%

Biohaven Pharmaceutical Holding Stock Forecast for 2026

January 2026 307 299.88 -2.32%
February 2026 300.86 301.84 0.33%
March 2026 304.92 298.98 -1.95%
April 2026 305.02 317.14 3.97%
May 2026 320.28 329.46 2.87%
June 2026 328.25 331.28 0.92%
July 2026 321.44 332 3.29%
August 2026 337.62 337 -0.18%
September 2026 343.74 347.82 1.19%
October 2026 347.82 349.46 0.47%
November 2026 339.08 345.42 1.87%
December 2026 338.58 347.49 2.63%

Biohaven Pharmaceutical Holding Stock Forecast for 2027

January 2027 347.49 350 0.72%